These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11274814)

  • 21. Evaluation about wettability, water absorption or swelling of excipients through various methods and the correlation between these parameters and tablet disintegration.
    Yang B; Wei C; Yang Y; Wang Q; Li S
    Drug Dev Ind Pharm; 2018 Sep; 44(9):1417-1425. PubMed ID: 29557692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new apparatus for real-time assessment of the particle size distribution of disintegrating tablets.
    Quodbach J; Kleinebudde P
    J Pharm Sci; 2014 Nov; 103(11):3657-3665. PubMed ID: 25223505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel approach of aceclofenac fast dissolving tablet.
    Dave V; Yadav S; Sharma S; Vishwakarma P; Ali N
    Pak J Pharm Sci; 2015 Jan; 28(1):37-41. PubMed ID: 25553683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of different fast melting disintegrants by means of a central composite design.
    Di Martino P; Martelli S; Wehrlé P
    Drug Dev Ind Pharm; 2005 Jan; 31(1):109-21. PubMed ID: 15704862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of chitosan as a disintegrant on the bioavailability of furosemide tablets: in vitro evaluation and in vivo simulation of novel formulations.
    Rasool BK; Fahmy SA; Galeel OW
    Pak J Pharm Sci; 2012 Oct; 25(4):815-22. PubMed ID: 23009999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chitin's Functionality as a Novel Disintegrant: Benchmarking Against Commonly Used Disintegrants in Different Physicochemical Environments.
    Chaheen M; Soulairol I; Bataille B; Yassine A; Belamie E; Sharkawi T
    J Pharm Sci; 2017 Jul; 106(7):1839-1848. PubMed ID: 28392454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of a method to study the dissolution behaviour of norfloxacin tablets.
    Córdoba Borrego M; Córdoba Díaz M; Reillo Martín A; Cienfuegos Rodriguez JM
    Pharm Acta Helv; 1995 Dec; 70(4):339-42. PubMed ID: 8765699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of wetting agents and disintegrants in development of danazol nanocrystalline tablets.
    Meruva S; Thool P; Gong Y; Karki S; Bowen W; Kumar S
    Int J Pharm; 2020 Mar; 577():119026. PubMed ID: 31940456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disintegrant Selection in Hydrophobic Tablet Formulations.
    Bauhuber S; Warnke G; Berardi A
    J Pharm Sci; 2021 May; 110(5):2028-2037. PubMed ID: 33181185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of disintegrant efficacy with fractal dimensions from real-time MRI.
    Quodbach J; Moussavi A; Tammer R; Frahm J; Kleinebudde P
    Int J Pharm; 2014 Nov; 475(1-2):605-12. PubMed ID: 25234864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simplified formulations with high drug loads for continuous twin-screw granulation.
    Meier R; Thommes M; Rasenack N; Krumme M; Moll KP; Kleinebudde P
    Int J Pharm; 2015 Dec; 496(1):12-23. PubMed ID: 26024821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of norfloxacin by fluorescence in the presence of different antacids: quantification of analytical interferences.
    Córdoba-Borrego M; Córdoba-Díaz M; Bernabé I; Córdoba-Díaz D
    J Pharm Biomed Anal; 1996 Jun; 14(8-10):977-82. PubMed ID: 8818003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formulation strategy towards minimizing viscosity mediated negative food effect on disintegration and dissolution of immediate release tablets.
    Zaheer K; Langguth P
    Drug Dev Ind Pharm; 2018 Mar; 44(3):444-451. PubMed ID: 29098885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A study of the compaction process and the properties of tablets made of a new co-processed starch excipient.
    Mužíková J; Eimerová I
    Drug Dev Ind Pharm; 2011 May; 37(5):576-82. PubMed ID: 21469946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced dissolution of sildenafil citrate as dry foam tablets.
    Sawatdee S; Atipairin A; Sae Yoon A; Srichana T; Changsan N
    Pharm Dev Technol; 2019 Jan; 24(1):1-11. PubMed ID: 28135896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimization of a formulation for direct compression using a simplex lattice design.
    Van Kamp HV; Bolhuis GK; Lerk CF
    Pharm Weekbl Sci; 1987 Oct; 9(5):265-73. PubMed ID: 3432036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Impact of Disintegrant Type, Surfactant, and API Properties on the Processability and Performance of Roller Compacted Formulations of Acetaminophen and Aspirin.
    Zhao J; Koo O; Pan D; Wu Y; Morkhade D; Rana S; Saha P; Marin A
    AAPS J; 2017 Sep; 19(5):1387-1395. PubMed ID: 28608238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Competing for water: A new approach to understand disintegrant performance.
    Ekmekciyan N; Tuglu T; El-Saleh F; Muehlenfeld C; Stoyanov E; Quodbach J
    Int J Pharm; 2018 Sep; 548(1):491-499. PubMed ID: 30018010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Designing robust immediate release tablet formulations avoiding food effects for BCS class 3 drugs.
    Zaheer K; Langguth P
    Eur J Pharm Biopharm; 2019 Jun; 139():177-185. PubMed ID: 30902732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic classification of tablet disintegrants by water uptake and force development kinetics.
    Quodbach J; Kleinebudde P
    J Pharm Pharmacol; 2014 Oct; 66(10):1429-38. PubMed ID: 24943882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.